New hope for kids with severe Crohn's disease in major drug trial
NCT ID NCT07298421
Summary
This study is testing a new drug called afimkibart to see if it can help children aged 2 to 17 who have moderate to severe Crohn's disease. The goal is to control the disease by reducing gut inflammation and symptoms in kids who haven't gotten enough help from other treatments. Researchers will measure if the drug helps kids feel better and if it causes any side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MODERATELY TO SEVERELY ACTIVE CROHNS DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.